Rhythm Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Rhythm Pharmaceuticals Inc share price today is $88.01, up -3.17%. The stock opened at $96.71 against the previous close of $90.31, with an intraday high of $99.64 and low of $86.745.
Rhythm Pharmaceuticals Inc Share Price Chart
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Share Price Performance
Rhythm Pharmaceuticals Inc Institutional Holdings
Rhythm Pharmaceuticals Inc Market Status
Rhythm Pharmaceuticals Inc Fundamentals
Market Cap 5971.53 M
PB Ratio 42.9393
PE Ratio 0.0
Enterprise Value 5717.53 M
Total Assets 481.19 M
Volume 3232819
Rhythm Pharmaceuticals Inc Company Financials
About Rhythm Pharmaceuticals Inc & investment objective
Company Information Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, Bardet-Biedl and Alström syndrome, Prader-Willi syndrome, and hypothalamic obesity. It is in Phase 3 clinical trials for treating acquired hypothalamic obesity, congenital hypothalamic obesity, pro-opiomelanocortin (POMC) and LEPR insufficiency obesities, SRC1 deficiency obesity, and SH2B1 deficiency obesity; and in phase 2 clinical trails for the treatment of Prader-Willi syndrome and MC4R deficiency. The company is also developing bivamelagon, an investigational oral small molecule MC4R agonist that is in phase 2 clinical trial for the treatment of MC4R pathway diseases; and RM-718, a next generation MC4R peptide agonist that is in phase 1 clinical trial for the treatment of hypothalamic obesity. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Organisation Biotechnology
Employees 414
Industry Biotechnology
CEO Dr. David P. Meeker M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Rhythm Pharmaceuticals Inc FAQs
What is the share price of Rhythm Pharmaceuticals Inc today?
The current share price of Rhythm Pharmaceuticals Inc is $88.01.
Can I buy Rhythm Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Rhythm Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Rhythm Pharmaceuticals Inc shares in India?
You can easily invest in Rhythm Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Rhythm Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Rhythm Pharmaceuticals Inc.
Can I buy fractional shares of Rhythm Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Rhythm Pharmaceuticals Inc?
Rhythm Pharmaceuticals Inc has a market cap of $5971.53 M.
In which sector does Rhythm Pharmaceuticals Inc belong?
Rhythm Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Rhythm Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Rhythm Pharmaceuticals Inc?
The PE ratio of Rhythm Pharmaceuticals Inc is N/A and the PB ratio is 42.94.